Real-time enrollment status for this hypochondroplasia clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 2:26 AM UTC
| NCT Number | NCT07126262 |
| Recruiting Status | Recruiting |
| Condition | Hypochondroplasia |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 9 sites in the US |
| Sponsor | BioMarin Pharmaceutical |
| Last Updated on CT.gov | March 31, 2026 (2 weeks ago) |
As of April 17, 2026: Clinical trial NCT07126262 is currently recruiting participants. This clinical trial study for hypochondroplasia is actively seeking new participants at 9 locations across the United States. The study is sponsored by BioMarin Pharmaceutical. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07126262 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07126262 was last updated 2 weeks ago (March 31, 2026). HelloStudys verifies this status automatically.